In particular, T cells in recurrent cSCC exhibited decreased activity of the TNF, IL-17, NF-kappa B, and NOD-like receptor signaling pathways, which may explain their low defense and weak killing ability. The gene discussed is TNF; the disease is skin squamous cell carcinoma.